mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs

Clinical trial NCT05686161 · UNKNOWN

Trial details

NCT number: NCT05686161
Sponsor: Stemirna Therapeutics
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Immunogenicity Safety Efficacy

Start date: 2022-10-19
Primary completion: 2022-12-07
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.